Anti-MAP therapy
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Anti-MAP therapy, covering 2020-05-01 to 2021-02-24. Get the full timeline:
Most recent: Clinical Trial Update: Open Label Efficacy and Safety of Anti-MAP (Mycobacterium Avium Ssp. Paratuberculosis) Therapy in Adult Crohn's Disease [Phase 3]